transdermal glp-1 patch How to Wear Patches: Current Status and Approved Alternatives Berberine Patch (Natural GLP-1) |

As we look beyond GLP-1 dominance, the future of T2D management will be defined by personalization, outcomes-based strategies, and broader access to next-generation therapies - shaping a more integrated and patient-centric approach to tackling this global epidemic.

PROMISE (CONT'D) Gastrointestinal discomfort is one of the leading reasons causing patients to discontinue use

8-12 weeks is optimal for ramp, and daily use is critical

Always adhere to the guidance provided by your healthcare professional

However, and despite these limitations, SGLT-2 inhibitors or a GLP-1RA with proven CV disease benefit are recommended in patients with type 2 diabetes and CV disease, established kidney disease, or HF [7,8,9,10]